Tower Research Capital LLC (Trc) Synthetic Biologics, Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.9 - $2.9 $2,300 - $3,511	1,211 Added 12.4%	10,979 $2,000
Q1 2022 May 12, 2022	SELL	$2.3 - $4.3 $113,868 - $212,884	-49,508 Reduced 83.52%	9,768 $3,000
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.5 $124,243 - $207,072	46,016 Added 347.03%	59,276 $16,000
Q3 2021 Nov 15, 2021	BUY	$4.3 - $5.8 $45,395 - $61,230	10,557 Added 390.57%	13,260 $6,000
Q2 2021 Aug 16, 2021	BUY	$4.6 - $7.2 $11,973 - $18,741	2,603 Added 2603.0%	2,703 $2,000

Q1 2021 May 17, 2021	SELL	$5.0 - $11.7 $73,475 - $171,931	-14,695 Reduced 99.32%	100 $0
Q4 2020 Feb 16, 2021	BUY	$2.9 - $4.6 $42,615 - $67,597	14,695 Added 14695.0%	14,795 $6,000
Q3 2018 Nov 13, 2018	BUY	$20.4 - $80.5 $2,039 - $8,050	100 New	100 $0

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.